CIM
MRNA icon

Contravisory Investment Management’s Moderna MRNA Stock Holding History

Contravisory Investment Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.7M Buy
24,218
+22,590
+1,388% +$1.17M 0.3% 54
2026
Q1 		$82.7K Buy
+1,628
New +$76K 0.02% 244

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Contravisory Investment Management's MRNA Position: Q2 2026 in Review

Contravisory Investment Management increased its Moderna (MRNA) stake by 1,388% in Q2 2026, buying an estimated $1.17M and bringing the position to 24,218 shares worth $1.7M. The position accounts for 0.3% of the portfolio, ranked #54.

Contravisory Investment Management first reported a position in MRNA in Q1 2026 and has held it in 2 quarters since. 777 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Contravisory Investment Management held 24,218 shares of Moderna worth $1.7M as of Q2 2026.
  • Contravisory Investment Management bought 22,590 Moderna shares in Q2 2026, an estimated $1.17M.
  • Moderna made up 0.3% of Contravisory Investment Management's portfolio in Q2 2026, its #54 holding.
  • Contravisory Investment Management first reported a position in Moderna in Q1 2026 and has held it in 2 quarters since.
  • 777 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Contravisory Investment Management's 13F filing for Q2 2026, filed 9 Jul 2026.